Filing Flows › Financials › TAO Synergies (TAOX)
TAO Synergies (TAOX) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · TAO Synergies (TAOX) Q2 2026 earnings results →
Q2 2026 Revenue up 2137% year over year to $89K
TAO Synergies made $89K in Q2 2026 (22× Y/Y). Operating margin n/m, net loss $9.3M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $89K in Q2 2026, up 2137% year over year and down 77% from the previous quarter.
Operating costs exceeded revenue by $1.6M, an operating margin of -1770.6%. Total costs fell 45% while revenue rose 2137%. The quarter ended with a net loss of $9.3M, after a profit of $4.3M the previous quarter. Net interest and other expense of $7.7M was the main reason.
Operating cash flow was −$875K. Non-cash charges added back $1K of depreciation and amortization. Working capital and other items added $8.4M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 13, 2026 | $89K | 22× | n/m | −$9.3M | −$875K |
| Q1 2026 | 10-Q | May 13, 2026 | $389K | — | -339.0% | $4.3M | −$1.7M |
| Q4 2025 | 10-K | Mar 31, 2026 | $92K | — | n/m | −$7.7M | −$2.5M |
| Q3 2025 | 10-Q | Nov 14, 2025 | $203K | — | -884.8% | −$3.9M | −$1.2M |
| Q2 2025 | 10-Q | Aug 14, 2025 | $4K | — | n/m | −$17.5M | −$749K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About TAO Synergies
From August 23, 2013 to December 6, 2020, Synaptogenix, Inc. (formerly known as Neurotrope Bioscience, Inc.) (the “Company” or “Synaptogenix”) was a wholly owned subsidiary of Neurotrope, Inc. (“Neurotrope”). Neurotrope’s operations were solely those of Synaptogenix. On May 17, 2020, Neurotrope announced plans for the complete legal and structural separation of Synaptogenix from Neurotrope (the “Spin-Off”). Under the Separation and Distribution Agreement between Neurotrope and Synaptogenix (the “Separation and Distribution Agreement”), Neurotrope distributed all of its equity interest in Synaptogenix to Neurotrope’s stockholders. Following the Spin-Off, Neurotrope does not own any equity interest in Synaptogenix, and Synaptogenix operates independently from Neurotrope.
In its own words, from its 10-K, filed Mar 31, 2026.
TAO Synergies against its Finance Services peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: 22× against the peers' median +18%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| TAOX TAO Synergies | Q2 2026 | $89K | 22× | n/m |
| AXP American Express | Q3 2026 | $20.1B | +9% | 22.6% |
| BTGO Bitgo Holdings | Q2 FY27 | $4.3B | +80% | -0.4% |
| General Motors Financial Company | Q3 2026 | $4.3B | -0.6% | 15.3% |
| SOFI SoFi Technologies | Q3 2026 | $1.4B | +44% | 22.9% |
| COIN Coinbase Global | Q3 2026 | $1.2B | -35% | 5.1% |
| CRCL Circle Internet Group | Q3 2026 | $865M | +17% | 24.1% |
| CHYM Chime Financial | Q3 2026 | $718M | +32% | 4.8% |
| GDOT Green DOT | Q2 2026 | $596M | +18% | -0.1% |
Source: TAO Synergies 10-Q on SEC EDGAR · CIK 1571934 · Finance Services
13F: who owns TAOX and who is buying
More on TAOX
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results